Chiesi Hungary Ltd.

This study tested Trimbow, a triple-combination inhaler, in over 1,300 people with moderate to severe COPD whose symptoms were not well-controlled with standard two-drug inhalers. Researchers measured changes in symptom scores and lung function over six months of routine care. Th…